Bay Area cryballoon ablation startup C2 Therapeutics just raised $11.6 million, according to a regulatory filing.
The company’s Coldplay Focal Cryoballoon Ablation System is meant to treat Barrett’s Esophagus – a fairly asymptomatic condition in which the tissue lining the esophagus gets replaced by a different kind of tissue – the sort that is found in the intestinal system. It’s most seen in people with acid reflux issues. Without treatment, a portion of these folks are at risk for a rare kind of cancer called esophageal adenocarcinoma.
C2’s device is administered through a scope, and expands as a balloon catheter that’s simultaneously inflated and cooled by an inert refrigerant delivered through a small, handheld unit, the company said. The balloon then conforms to the shape of the esophagus.
Solera Health’s Playbook To Beat Rising Employer Expenses
Solera Health is working to streamline employer contracting with health tech.
The company’s raised about $10 million since 2007, according to regulatory filings.
[Photo from Flickr user zzzack]